Rivaroxaban

Overview

Rivaroxaban is an oral anticoagulant used to prevent and treat blood clots. It works as a direct factor Xa inhibitor, which disrupts the blood coagulation cascade.

API suppliers (7)

Suppliers of Rivaroxaban backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Zhejiang Hisun Pharmaceutical Co., Ltd.China3 active DMF
• Dr. Reddy's Laboratories Ltd.India2 active DMF
• INTERQUIM SA1 active DMF
• AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)India1 active DMF
• INTERQUIM SA1 active DMF
• INTERQUIM SA1 active DMF
• Neuland Laboratories LimitedIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (60 approved US products), the latest listed US patent on Rivaroxaban expires 16 Aug 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas